Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves-Marie Pers

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
La Revue Du Praticien|April 3, 2020
[Is there an increasing frequency of osteoarthritis in young people?]Yves-Marie Pers
Nature Reviews. Rheumatology|October 1, 2020
Revisiting the cardiovascular risk of hydroxychloroquine in RAYves-Marie Pers, Guillaume Padern
Journal of Clinical Medicine|August 4, 2015
Mesenchymal Stromal Cells: Updates and Therapeutic Outlook in Rheumatic DiseasesYves-Marie Pers, Christian Jorgensen
Immunotherapy|August 4, 2016
Perspectives of ofatumumab as CD20 targeted therapy in rheumatoid arthritis and other autoimmune diseasesYves Marie Pers, Christian Jorgensen
Nature Reviews. Rheumatology|January 17, 2013
MicroRNA in 2012: Biotherapeutic potential of microRNAs in rheumatic diseasesYves-Marie Pers, Christian Jorgensen
Hormone Molecular Biology and Clinical Investigation|April 20, 2016
Adipose derived stem cells for regenerative therapy in osteoarticular diseasesYves-Marie Pers, Christian Jorgensen
Annals of Translational Medicine|February 5, 2020
Taking in consideration the bystander effects of articular senescenceJean-Marc Brondello, Yves-Marie Pers
Frontiers in Immunology|September 13, 2021
Editorial: The Role of Metabolism in MSC-Mediated ImmunomodulationYves-Marie Pers, Christian Jorgensen, Maroun Khoury
Joint Bone Spine|July 12, 2015
Efficacy of Tocilizumab in the treatment of Eosinophilic fasciitis: Report of one caseFrancisco Espinoza, Christian Jorgensen, Yves-Marie Pers
Joint Bone Spine|March 11, 2026
From Multiple Sclerosis to Spondyloarthritis: A Case of Teriflunomide-Associated Immune-Mediated DiseaseGaetan Noeppel, Raluca Prunel, Yves-Marie Pers
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
La Revue Du Praticien|April 3, 2020
[Is there an increasing frequency of osteoarthritis in young people?]Yves-Marie Pers
Nature Reviews. Rheumatology|October 1, 2020
Revisiting the cardiovascular risk of hydroxychloroquine in RAYves-Marie Pers, Guillaume Padern
Journal of Clinical Medicine|August 4, 2015
Mesenchymal Stromal Cells: Updates and Therapeutic Outlook in Rheumatic DiseasesYves-Marie Pers, Christian Jorgensen
Immunotherapy|August 4, 2016
Perspectives of ofatumumab as CD20 targeted therapy in rheumatoid arthritis and other autoimmune diseasesYves Marie Pers, Christian Jorgensen
Nature Reviews. Rheumatology|January 17, 2013
MicroRNA in 2012: Biotherapeutic potential of microRNAs in rheumatic diseasesYves-Marie Pers, Christian Jorgensen
Hormone Molecular Biology and Clinical Investigation|April 20, 2016
Adipose derived stem cells for regenerative therapy in osteoarticular diseasesYves-Marie Pers, Christian Jorgensen
Annals of Translational Medicine|February 5, 2020
Taking in consideration the bystander effects of articular senescenceJean-Marc Brondello, Yves-Marie Pers
Frontiers in Immunology|September 13, 2021
Editorial: The Role of Metabolism in MSC-Mediated ImmunomodulationYves-Marie Pers, Christian Jorgensen, Maroun Khoury
Joint Bone Spine|July 12, 2015
Efficacy of Tocilizumab in the treatment of Eosinophilic fasciitis: Report of one caseFrancisco Espinoza, Christian Jorgensen, Yves-Marie Pers
Joint Bone Spine|March 11, 2026
From Multiple Sclerosis to Spondyloarthritis: A Case of Teriflunomide-Associated Immune-Mediated DiseaseGaetan Noeppel, Raluca Prunel, Yves-Marie Pers
Pageof 11